TEVA-Losartan Product Recall (2021-05-25)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
TEVA-Losartan 50 mg Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 0010219, 0020419, 0030419, 0031018, 0040120, 0040919, 0050620, 0050919, 0060620, 0070620, 0010120, 0020120 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| B. TEVA-Losartan 25 mg Tablet | DIN 02380838 | Tablet | Losartan Potassium 25 mg |
| 2010219, 2010420, 2020219, 2020420, 2030420, 2040219, 2060419, 2080619, 2080918, 2091018, 2101018, 2161119, 2171119, 2030218, 2070419, 2140919, 2181119, 2191119 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| C. TEVA-Losartan 100 mg Tablet | DIN 02357976 | Tablet | Losartan Potassium 100 mg |
| 1040120, 1030120, 1040419, 1050419, 1060419, 1070419, 1080918, 1090918, 1090819, 1100819, 1101018, 1110819, 1111018, 1121018, 1130819, 1180919, 1010120, 1030218, 1080419, 1120819, 1141018 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| TEVA-Losartan 50 mg Tablet | DIN 02357968 | Tablet | Losartan Potassium 50 mg |
-
TEVA-Losartan 50 mg Tablet
-
TEVA-Losartan 25 mg Tablet
-
TEVA-Losartan 100 mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.